Covered recipient · General Payments record
ANKITA R BAHUVA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,272.12
- Reported across 142 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $194.00 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $64.24 | 3 |
| Amgen Inc. | $39.70 | 2 |
| Novo Nordisk AS | $27.15 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.29 | 1 |
| GlaxoSmithKline, LLC. | $21.12 | 1 |
| E.R. Squibb & Sons, L.L.C. | $20.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.58 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106023885 | CMS |
| ABBVIE INC. | $23.25 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106023887 | CMS |
| ABBVIE INC. | $21.41 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106023889 | CMS |
| Amgen Inc. | $17.28 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111522523 | CMS |
| Amgen Inc. | $22.42 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111522525 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.50 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101213032 | CMS |
| GlaxoSmithKline, LLC. | $21.12 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116368894 | CMS |
| Novartis Pharmaceuticals Corporation | $21.29 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087286839 | CMS |
| Novo Nordisk Inc | $13.50 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096648726 | CMS |
| Novo Nordisk Inc | $13.65 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097017733 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.